Personal Capital Advisors Corp grew its stake in ICU Medical, Inc. (NASDAQ:ICUI – Get Rating) by 4.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,378 shares of the medical instruments supplier's stock after acquiring an additional 2,143 shares during the quarter. Personal Capital Advisors Corp owned about 0.23% of ICU Medical worth $12,107,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Quadrant Capital Group LLC lifted its position in ICU Medical by 81.5% during the first quarter. Quadrant Capital Group LLC now owns 118 shares of the medical instruments supplier's stock worth $26,000 after buying an additional 53 shares during the period. Covestor Ltd raised its holdings in shares of ICU Medical by 86.4% in the 1st quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 57 shares during the period. Van ECK Associates Corp raised its holdings in shares of ICU Medical by 16.1% in the 1st quarter. Van ECK Associates Corp now owns 469 shares of the medical instruments supplier's stock worth $104,000 after purchasing an additional 65 shares during the period. Group One Trading L.P. raised its holdings in shares of ICU Medical by 54.6% in the 1st quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier's stock worth $126,000 after purchasing an additional 200 shares during the period. Finally, Advisor Group Holdings Inc. grew its stake in shares of ICU Medical by 7.5% in the fourth quarter. Advisor Group Holdings Inc. now owns 847 shares of the medical instruments supplier's stock valued at $202,000 after buying an additional 59 shares in the last quarter. 90.20% of the stock is currently owned by hedge funds and other institutional investors.
Get
ICU Medical alerts:
Analyst Upgrades and Downgrades
ICUI has been the subject of a number of recent research reports. Raymond James lowered their target price on ICU Medical from $208.00 to $190.00 and set an "outperform" rating for the company in a research note on Tuesday, August 9th. KeyCorp lowered their target price on ICU Medical from $230.00 to $225.00 in a research note on Tuesday, August 9th. Finally, StockNews.com upgraded ICU Medical from a "sell" rating to a "hold" rating in a research note on Monday, September 5th.
ICU Medical Price Performance
Shares of NASDAQ ICUI opened at $172.43 on Monday. ICU Medical, Inc. has a fifty-two week low of $154.73 and a fifty-two week high of $254.96. The business has a 50 day moving average price of $168.58 and a two-hundred day moving average price of $191.13. The company has a quick ratio of 1.25, a current ratio of 2.45 and a debt-to-equity ratio of 0.78. The firm has a market cap of $4.12 billion, a PE ratio of 410.56 and a beta of 0.57.
ICU Medical (NASDAQ:ICUI – Get Rating) last issued its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.37 earnings per share for the quarter, missing analysts' consensus estimates of $1.68 by ($0.31). ICU Medical had a net margin of 0.31% and a return on equity of 6.97%. The business had revenue of $561.00 million for the quarter, compared to analyst estimates of $569.30 million. During the same quarter last year, the business earned $1.57 EPS. ICU Medical's revenue for the quarter was up 74.4% compared to the same quarter last year. Sell-side analysts expect that ICU Medical, Inc. will post 5.23 earnings per share for the current fiscal year.
ICU Medical Company Profile
(Get Rating)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
Featured Stories
- Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
- Here's Why the CPI Report will Dictate the Market Bottom
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Get Rating).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
